A molecule that is no longer BPC-157
There is no TGA-registered BPC-157 product for therapeutic use in Australia, and as of June 2024 BPC-157 is a Schedule 4 (prescription-only) substance, meaning any legal supply must come through a doctors prescription via a compounding pharmacy
Increasing liver production of lecithin which helps lower serum cholesterol levels
Neither peptide is FDA-approved for performance or injury treatment
But here's the crucial caveat: altering fundamental metabolic pathways, no matter how promising the initial data appears, invariably comes with a spectrum of potential responses
Whether youre dealing with a stubborn tendon injury, chronic digestive issues, or want to optimize recovery after surgery, BPC-157 offers a scientifically grounded approach to tissue repair